The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fitzgerald Thomas A since 2022.
This trader's CIK number is 1854168.
At the time of last reporting, Fitzgerald Thomas A was the Chief Financial Officer of Transcode Therapeutics, Inc.. (stock ticker symbol RNAZ).
Also see all insider trading activities at Transcode Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RNAZ | 49,350 | $25,168 | 0 | $0 | 0 | $0 |
| 2022 | RNAZ | 12,000 | $15,240 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-28 | RNAZ | Buy | 49,350 | .51 | 25,168 |
| 2022-06-16 | RNAZ | Buy | 12,000 | 1.27 | 15,240 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fitzgerald Thomas A (Chief Financial Officer of Transcode Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.